AzTrials
AzTrials

Alcohol Use DisorderNCT07150156

A Non-Inferiority Trial of an Electronic vs Face-to-face Brief Intervention After Alcohol Screening in Two Countries

A study testing brief intervention following alcohol screening in people with Alcohol Use Disorder, run by HBSA at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare two different strategies to deliver brief interventions to people whose scores on the Alcohol Use Disorders Identification Test (AUDIT) suggest that their level of alcohol use may be unhealthy. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Alcohol Use Disorder
What is being tested?
brief intervention following alcohol screening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,439 participants
Where
2 sitesin 2 countries
Study dates
17 Feb 2025to 4 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Aged 18 and above
  • AUDIT screening score of 8 or more

Who cannot join

  • Having been screened for alcohol use within the past 6 months

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Mexico1 site
  • IMSS Bienestar

    Zacatecas City, Zacatecas

Other trials in Mexico

South Africa1 site
  • Friends for Life

    Johannesburg, Gauteng

Other trials in South Africa

About this study

Official title: Study Protocol for a Non-inferiority Trial of Electronic Versus Face-to-face Brief Intervention Following Alcohol Screening in Zacatecas, Mexico and Alexandra Township, South Africa

The goal of this clinical trial is to compare two different strategies to deliver brief interventions to people whose scores on the Alcohol Use Disorders Identification Test (AUDIT) suggest that their level of alcohol use may be unhealthy. Brief interventions typically seek to increase the awareness of people whose alcohol use may be unhealthy of the extent and potential adverse consequences of their substance use, and then to provide guidance and motivate them to reduce their consumption. Due to limitations in the use of traditional brief interventions delivered face-to-face by health care providers, applications have been developed to support the electronic delivery of brief interventions. The main question posed in this study is: Is an electronic brief intervention (eBI) delivered via an app on a handheld device at least as effective in reducing alcohol consumption as a traditional in-person brief intervention delivered by a facilitator, who is a trained health educator? We expect that eBI will not be significantly less effective than face-to-face brief intervention.

To test the efficacy of eBI compared to traditional in-person brief intervention, researchers will compare changes in average 30-day quantity and frequency of drinking alcohol, AUDIT scores, and in several additional measures of outcomes related to risky or hazardous alcohol use between participants who received an eBI and those who received a face-to-face brief intervention. In this non-inferiority trial, the intervention (i.e., electronic brief intervention via an app) will be considered effective if it yields reductions in participants' risky or hazardous alcohol use that are no less than those produced by the comparison condition (i.e., a traditional brief intervention through an in-person interaction).

Read more

Participants will:

  • be invited to complete an alcohol screening using the AUDIT
  • be invited to be in a study of alcohol use patterns over time if they have an AUDIT score of 8 or higher
  • take a brief survey with demographic and additional recent alcohol use questions
  • receive either an eBI or an in-person brief intervention
  • complete two additional surveys at 3- and 6-month intervals after the first survey to collect information on alcohol use over time
Read the detailed description

Background and Study Purpose

As is well-documented by the World Health Organization (WHO), alcohol abuse remains a major health hazard worldwide, responsible for 5.3 percent of all deaths annually. It also contributes to over 200 conditions related to disease and injury, which include an array of behavioral and mental health disorders. There is now a substantial body of literature suggesting the effectiveness of Screening and Brief Intervention (SBI) as a strategy to identify people at high risk for alcohol use disorder, and to invite them, within the context of a short motivational interview, to reflect on their drinking patterns and develop a realistic and achievable plan to reduce their consumption. The screening component of SBI typically relies on the Alcohol Use Disorders Identification Test (AUDIT), which comprises two parts. The first is a 3-item assessment (the AUDIT-C); individuals who score 8 or higher are then invited to: (1) respond to 7 additional questions about their alcohol consumption (the AUDIT-7) and (2) participate in a brief intervention that is typically conducted by their primary health care provider or a staff member.

There are a variety of reasons, however, why brief interventions may fail to fulfill expectations of their positive effects. Eligible participants may be reluctant to engage fully in brief interventions because of the stigma attached to doing so; and primary health care providers may lack the time, attention, and confidence in their ability to conduct the brief intervention, or delegate responsibility for its administration to staff members who are insufficiently trained to deliver the intervention as intended, which includes establishing a sufficient rapport with the participant.

Consideration has thus been given to strategies to automate the delivery of brief interventions so that they can be self-administered electronically. Prototypes of this delivery mechanism are under development, and are sufficiently far advanced that they warrant investigations of their effectiveness. The key research question to be addressed by this study is:

  • Are brief interventions, as electronically self-administered via an app on handheld devices, at least as effective in reducing the 30-day quantity and frequency of alcohol consumption as brief interventions administered in person by health care providers?

Note that the study's purpose is not to determine whether the administration of brief interventions via a handheld device is superior to that of an in-person administration, but to investigate whether the two modes of delivery are at least of equal effectiveness.

Study Setting

This study will be conducted in communities in two low- and middle-income countries: Zacatecas, Mexico and Alexandra Township, South Africa. In each site approximately seven to nine hospitals and health care clinics will participate in the study.

Institutional Recruitment Procedures

A country-specific study contractor will recruit the hospitals and clinics where the SBI will be delivered. All participating institutions will express their willingness to permit the contractor's trained facilitators (health educators) to approach patients in waiting areas and administer the AUDIT screening tool to them via an electronic device. For those patients who score 8 or higher on the AUDIT-C, the institutions will agree to:

  • support the administration of the AUDIT-7;
  • agree to and support the assignment of all participating clinics on alternating weeks to either the traditional in-person brief intervention or the electronic brief intervention. Thus all patients qualifying for the study in any given week will be assigned to one group, and all those in the subsequent week will be assigned to the other group.

Study Participant Requirements and Procedures

All patients who are at least 18 years old and score 8 or above on the AUDIT will be eligible and recruited for the study as long as they have not been screened in the past six months. They will be informed of their eligibility via the consent language presented in the app after the screening and before the study survey (those who do not qualify for the study do not see the consent language or the survey but go directly from the screening to their brief intervention). Specifically, the consent form on the device will inform them that:

  • they are eligible to participate in a study on alcohol use patterns over time;
  • they will be invited to answer a few more questions about their alcohol use;
  • they will be asked to complete similar surveys in three months and again at six months, with various options, i.e., at the time of a follow-up clinic visit (for those with chronic health conditions), at a meeting with a clinic staff person at a convenient time and location, or via a phone interview in South Africa and via a link to the survey sent to them so they can complete it on their phone or other device at home or a phone interview in Mexico;
  • they will receive an incentive at the time of each survey with each successive survey incentive of increased value compared to the previous one (small cash payments in Mexico; a mobile airtime credit at baseline and grocery vouchers at the two follow-up surveys in South Africa); and
  • they will be asked to provide personal contact information to be used to recontact them at each of the two follow-up intervals.

Study Sample

All screened patients who are are aged 18 or older, who score 8 or higher on the AUDIT, and who have not been screened in the past 6 months will be eligible to participate in the study. Initial targets were to enroll 460 participants (230 in each brief intervention condition or study arm) in each country. At this point, Mexico has enrolled 563 participants (289 traditional BI; 274 electronic BI). Baseline data collection is still ongoing in South Africa.

Analysis Plan

In this non-inferiority trial, the null hypothesis is that the intervention (i.e., a BI delivered electronically via an app) is inferior to the comparison (i.e., an in-person brief intervention, or business as usual). This would be reflected in a statistically significant greater reduction in drinking alcohol post-intervention among those receiving an in-person BI compared to those receiving an electronic BI.

Being tested
brief intervention following alcohol screening
Keywords
alcohol use disorder, screening, brief intervention, electronic
Medical subject headings
Alcoholism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • brief intervention following alcohol screeningBehavioural

    Provision of a brief intervention via an electronic app

  • brief intervention following alcohol screeningBehavioural

    Provision of a brief intervention via a face-to-face interaction with a trained facilitator

Study groups in NCT07150156
Study groupRoleWhat they receive
electronic brief interventionExperimentalParticipants receive an electronic brief intervention via an app accessed on a handheld device
Receives: Behavioral: brief intervention following alcohol screening
in-person brief interventionActive comparatorParticipants receive a face-to-face brief intervention via a personal discussion with a trained facilitator
Receives: Behavioral: brief intervention following alcohol screening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Average daily quantity X frequency within last 30 days

    In the past 30 days, on how many days did you have a whole drink, more than a sip or taste, of any alcoholic beverage? In the past 30 days, on the days when you drank alcohol, about how many whole drinks did you typically have?

    Measured: 3 months and 6 months

Secondary outcomes (3)
  1. Maximum quantity x frequency within last 30 days

    You said you usually had [Number from Alc 2] whole drinks when you drank alcohol. Thinking about the past 30 days, what was the greatest number of drinks with alcohol you had on any one day? In the past 30 days, on how many days did you have [Number from Alc 3] alcoholic drinks?

    Measured: 3 months and 6 months

  2. 30-day frequency of 6+ drinks

    On how many days in the past 30 days did you have 6 or more alcoholic drinks on one occasion?

    Measured: 3 months and 6 months

  3. Past 3 months total 10-item AUDIT score

    AUDIT-C + AUDIT 7 scores

    Measured: 3 months and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2025
  2. Study start17 Feb 2025
  3. Primary completion4 Dec 2025
  4. Study completion4 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,439 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07150156
Sponsor's protocol ID
HBSA
Status last verified
Sep 2026
First submitted
25 Aug 2025
Last updated
21 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All individual participant data held by this study's investigators will be made available to other researchers following the conclusion of this study. Note that all data will be fully deidentified.

Questions about this trial

What is this clinical trial studying?

A study testing brief intervention following alcohol screening in people with Alcohol Use Disorder, run by HBSA at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Mexico, South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Average daily quantity X frequency within last 30 days (time frame: 3 months and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in